Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniel H.S. Brundel"'
Autor:
Cameron J. Nowell, Daniel H.S. Brundel, Lisa M. Kaminskas, Gracia Gracia, Orlagh M. Feeney, Christopher J.H. Porter, Michelle M. McIntosh, David W. Kang, Estelle J.A. Suys
Publikováno v:
Nanomedicine. 16:275-292
Aim: Delivery of nanoparticles (NPs) to tumors can be impeded by high levels of hyaluronan (HA) in the stroma. Enzymatic depolymerization of HA with PEGylated hyaluronidase (PEGPH20) improves the delivery of antibodies to tumors. However, it is unkno
Autor:
Daniel H.S. Brundel, David W. Kang, Orlagh M. Feeney, Christopher J.H. Porter, Michelle P. McIntosh, Renee Clift, Ian K. Styles, Tri-Hung Nguyen
Publikováno v:
Journal of Controlled Release. 315:85-96
Interstitial, e.g. subcutaneous (SC) or intradermal (ID), administration of monoclonal antibodies (mAb) is less invasive than intravenous administration and leads to mAb uptake into both lymphatic and blood capillaries draining the injection site. In
Autor:
Daniel H.S. Brundel, Christopher J.H. Porter, Colin W. Pouton, David K. Chalmers, Estelle J.A. Suys
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 331
Drug absorption from lipid-based formulations (LBFs) in the gastrointestinal (GI) tract is the result of a series of processes, including formulation dispersion, interaction with biliary and pancreatic secretions, drug solubilisation and supersaturat
Autor:
Natalie L. Trevaskis, Daniel H.S. Brundel, Enyuan Cao, Lisa M. Kaminskas, Orlagh M. Feeney, Christopher J.H. Porter, Gracia Gracia
Publikováno v:
Advanced drug delivery reviews. 160
The advent of immunotherapy has revolutionised the treatment of some cancers. Harnessing the immune system to improve tumour cell killing is now standard clinical practice and immunotherapy is the first line of defence for many cancers that historica
Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
Autor:
Cees Neef, Ron H.J. Mathijssen, T. van Gelder, van Robert Leeuwen, Daniel H.S. Brundel, David M. Burger, Frank G A Jansman
Publikováno v:
British Jounal of Cancer, 108(5), 1071-1078. Nature Publishing Group
British Journal of Cancer, 108(5), 1071-1078. Nature Publishing Group
British Journal of Cancer, 108, 1071-8
British Journal of Cancer
British Journal of Cancer, 108, 5, pp. 1071-8
British Journal of Cancer, 108(5), 1071-1078. Nature Publishing Group
British Journal of Cancer, 108, 1071-8
British Journal of Cancer
British Journal of Cancer, 108, 5, pp. 1071-8
Contains fulltext : 117477.pdf (Publisher’s version ) (Open Access) Background:Potential drug-drug interactions (PDDIs) in patients with cancer are common, but have not previously been quantified for oral anticancer treatment. We assessed the preva
Autor:
R. van Leeuwen, Ron H.J. Mathijssen, Cees Neef, David M. Burger, Daniel H.S. Brundel, T. van Gelder, Frank G A Jansman
Publikováno v:
Annals of Oncology, 23(Suppl. 9):1402P, 456-456. Oxford University Press